Obesity Clinical Trial
— OGANOfficial title:
Obesity and Pregnancy : Study of Factors Influencing Participation in a Program Combining Physical Activity and Nutritional Counseling
Verified date | February 2019 |
Source | University Hospital, Lille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background:
Obesity increasingly affects young women and contributes to increased maternal, fetal and
neonatal complications. Maternal obesity contributes to the subsequent development of
childhood obesity not only through social and environmental mechanisms but also through
biological processes referring to the original concept of the developmental health and
disease. Data suggest that management during pregnancy through nutrition counseling and
adequate physical activity will help to break the familial vicious circle of obesity. To help
program to be effective it is important to understand the factors that modulate
participation. However, few studies have been conducted to assess the determinants that
influence participation.
Goal:
The main objective is to analyze 15 factors that influence participation in a program
combining physical activity and nutritional counseling among pregnant women with BMI ≥ 25
kg/m2. Secondary objectives are :
- to identify the data that influence adherence and to show that assiduous women will have
a better control of weight gain and a reduction of maternal and fetal complications.
- to understand the biological mechanisms involved
Strategy and method:
A prospective research evaluating the participation in an educational program, including
nutritional support and adequate physical activity, will be offered to overweight and obese
pregnant women. The program will last 12 weeks, and will include three workshops on diet of
the pregnant and lactating women, and the young child. Physical activity sessions will be
offered once a week. Fifteen independent variables likely to influence participation will be
analyzed. The association between participation and the risk of maternal and fetal pregnancy
complications related to obesity will be analysed. Meanwhile, more fundamental research will
be considered to determine of the biological factors involved.
Status | Terminated |
Enrollment | 195 |
Est. completion date | October 29, 2018 |
Est. primary completion date | October 29, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion criteria : - Overweight and obese pregnant women - Age from 18 to 45 years old - Singleton pregnancy between 12+0 to 22+6 weeks of pregnancy Exclusion criteria: - History of more than 2 miscarriages - Severe heart disease (arrhythmias, history of myocardial infarction) - Multiple pregnancy - Unstable thyroid disease - Uncontrolled hypertension - Pre-gestational diabetes - Bariatric surgery - Any medical condition that may interfere with physical activity during pregnancy - Minor or absence of health insurance - Trusteeship or tutorship - Refusal to participate in research |
Country | Name | City | State |
---|---|---|---|
France | CHRU,Hôpital Jeanne de Flandres | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille | Région Nord-Pas de Calais, France, University of Lille Nord de France |
France,
Deruelle P. [Obesity and pregnancy]. Gynecol Obstet Fertil. 2011 Feb;39(2):100-5. doi: 10.1016/j.gyobfe.2010.12.001. Epub 2011 Feb 12. French. — View Citation
Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, Mol BW, Coomarasamy A, Khan KS. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012 May 16;344:e2088. doi: 10.1136/bmj.e2088. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participant that will participate to the program | at 36 weeks of gestation (WG) | ||
Secondary | Macrosomia / Birth weight | at birth | ||
Secondary | Gestational weight gain | at birth | ||
Secondary | Pregnancy complications | Gestational diabetes, gravidic hypertension and preeclampsia | between 28 weeks of gestation and term | |
Secondary | Number of patients with C-section or an instrumental extraction | C-section vaginal delivery, instrumental extraction | at birth | |
Secondary | eating behavior before, during and after the program | Three eating factors questionnaire / semi-qualitative questionnaire | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum | |
Secondary | Questionnaire of physical activity | french questionnaire of physical activity | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum | |
Secondary | Questionnaire for self-esteem | Positive and Negative Affect Schedule (PANAS) questionnaire | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum | |
Secondary | number of neonates with neonatal trauma | fractures, shoulder dystocia, brachial plexus injury | at birth | |
Secondary | Apgar score | at birth | ||
Secondary | Arterial umbilical pH | at birth | ||
Secondary | number of neonates with hyperbilirubinemia | total serum bilirubin level > 86 micro mol/L | Within 7 days after birth | |
Secondary | Number of neonates needing intensive care transfer | Within 7 days after birth | ||
Secondary | Neonatal adiposity | measurement of shoulder fat thickness in mm | at birth | |
Secondary | Maternal weight | within 6-8 weeks post-partum | ||
Secondary | Infant weight | within 6-8 weeks post-partum | ||
Secondary | duration of Breastfeeding | in weeks | within 6-8 weeks post-partum | |
Secondary | Maternal Plasmatic cholesterol levels before, during and after the program | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | Maternal Plasmatic leptin levels | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | maternal plasmatic glycemic levels | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | microRNA levels in maternal milk | 2 or 3 days after birth | ||
Secondary | Physical activity measured with accelerometers | measurements for 1 week | between 32 and 34 Weeks of gestation and within 6-8 weeks post-partum | |
Secondary | Maternal Plasmatic triglyceride levels before, during and after the program | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | Maternal Plasmatic Apolipoprotein levels before, during and after the program | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | Maternal plasmatic apelin levels | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | maternal plasmatic insulin levels | between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth | ||
Secondary | Pittsburgh Sleep Quality Index | is a self-report questionnaire that assesses sleep quality over a 1-month time interval. | during 7 days between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |